Laurel Wealth Advisors (North Carolina)’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Buy |
1,020
+420
| +70% | +$247K | 0.01% | 315 |
|
|
2025
Q1 | $948 | Hold |
600
| – | – | ﹤0.01% | 640 |
|
|
2024
Q4 | $1.07K | Hold |
600
| – | – | ﹤0.01% | 660 |
|
|
2024
Q3 | $3.64K | Hold |
600
| – | – | ﹤0.01% | 549 |
|
|
2024
Q2 | $3.16K | Hold |
600
| – | – | ﹤0.01% | 522 |
|
|
2024
Q1 | $5.09K | Hold |
600
| – | – | ﹤0.01% | 484 |
|
|
2023
Q4 | $3.96K | Hold |
600
| – | – | ﹤0.01% | 470 |
|
|
2023
Q3 | $1.85K | Hold |
600
| – | – | ﹤0.01% | 513 |
|
|
2023
Q2 | $1.62K | Hold |
600
| – | – | ﹤0.01% | 522 |
|
|
2023
Q1 | $1.78K | Hold |
600
| – | – | ﹤0.01% | 522 |
|
|
2022
Q4 | $1.51K | Hold |
600
| – | – | ﹤0.01% | 497 |
|
|
2022
Q3 | $1K | Hold |
600
| – | – | ﹤0.01% | 507 |
|
|
2022
Q2 | $2K | Hold |
600
| – | – | ﹤0.01% | 527 |
|
|
2022
Q1 | $4K | Hold |
600
| – | – | ﹤0.01% | 498 |
|
|
2021
Q4 | $9K | Hold |
600
| – | – | ﹤0.01% | 417 |
|
|
2021
Q3 | $5K | Hold |
600
| – | – | ﹤0.01% | 472 |
|
|
2021
Q2 | $17K | Hold |
600
| – | – | ﹤0.01% | 395 |
|
|
2021
Q1 | $17K | Hold |
600
| – | – | ﹤0.01% | 365 |
|
|
2020
Q4 | $7K | Hold |
600
| – | – | ﹤0.01% | 436 |
|
|
2020
Q3 | $4K | Hold |
600
| – | – | ﹤0.01% | 434 |
|
|
2020
Q2 | $4K | Hold |
600
| – | – | ﹤0.01% | 430 |
|
|
2020
Q1 | $2K | Hold |
600
| – | – | ﹤0.01% | 466 |
|
|
2019
Q4 | $3K | Hold |
600
| – | – | ﹤0.01% | 472 |
|
|
2019
Q3 | $2K | Hold |
600
| – | – | ﹤0.01% | 472 |
|
|
2019
Q2 | $1K | Hold |
600
| – | – | ﹤0.01% | 498 |
|
|
2019
Q1 | $2K | Hold |
600
| – | – | ﹤0.01% | 454 |
|
|
2018
Q4 | $1K | Buy |
+600
| New | +$1K | ﹤0.01% | 478 |
|